Manage Your Liver
Q:

Case studies: Fatty liver, Elevated ALT and Fatigue

Case studies: Fatty liver, Elevated ALT and Fatigue
A:

Fatty liver (NAFLD) is becoming increasingly common in our sociality. This silent liver disease can causes chronic injury to liver cells and damaging liver function, it could also leads to fibrosis, cirrhosis and even liver cancer.

 

Tom, who is a business man in his mid 40s, his busy work life and poor diet has lead him to fatty liver. It started when he felt fatigue with lack of energy for a period of time, which he first thought is due to the lack of sleep. But with no signs of improvement, he went for a body check. Tom was found to have fatty liver with early stage of fibrosis with ALT level at 91. 

 

Fatty liver is often hard to spots until advance stages due to the lack of clear symptoms. In Tom’s case, it is lucky for him to have found the problem before the liver develops cirrhosis. His doctor has recommend him to adjust his diet and exercise, as there is no medication for fatty liver or fibrosis. After 6 months of trying with no noticeable improvement, he starting using our liver therapy.

 

=========

Tom:

“I have just finished my third order. It took 3 weeks to normalize my liver function, ALT lower to 3, prior to that they had been getting worse. The tiredness has gone completely, I feel more awake and energetic especially in the afternoon. Liver scan also shows improve on the fibrosis.

=========

 

The danger of fatty liver is that it causes inflammation and damages liver cells. What YHK can do is helps to protect and enhance liver function in a number of ways, research found that YHK can:

 

  1. Reduce fat generation and increase lipid metabolism.1
  2. Reduce the accumulation of fat in the liver.2
  3. Reduce blood lipid elevation through its antioxidant mechanism.3
  4. Stop inflammation in the liver and anti- fibrosis.

 

After using YHK, Tom’s liver will be able to function better and damage to the liver cells will reduce and lowering his ALT level. Symptoms will naturally decrease with the improve liver function, therefore recovering his energy level.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. NAFLD is one of the most common causes of liver disease in the United States. Between 30 and 40 percent of adults in the United States have NAFLD. About 3 to 12 percent of adults in the United States have NASH (a form of NAFLD in which you have inflammation and liver cell damage). [1] Recent research found that NAFLD not only increases the risk of chronic liver diseases such as NASH, l
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
Hit Questions
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us